5.49
8.50%
-0.51
Precedente Chiudi:
$6.00
Aprire:
$5.9
Volume 24 ore:
104.64K
Relative Volume:
0.21
Capitalizzazione di mercato:
$6.46M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-58.91%
1M Prestazione:
-28.79%
6M Prestazione:
-88.24%
1 anno Prestazione:
+0.00%
Autonomix Medical Inc Stock (AMIX) Company Profile
Nome
Autonomix Medical Inc
Settore
Industria
Telefono
832-277-7816
Indirizzo
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Confronta AMIX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
5.49 | 6.46M | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option - The Manila Times
Autonomix Medical, Inc. Announces Closing of $10.0 Million - GlobeNewswire
Autonomix Medical Closes $10M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Autonomix Medical stock dips after pricing $9M securities offering - MSN
Autonomix Medical (NASDAQ:AMIX) vs. Perspective Therapeutics (NYSE:CATX) Critical Review - Defense World
Autonomix Medical (AMIX) & Its Rivals Head to Head Contrast - Defense World
Autonomix Medical Prices of $9.0 Million Underwritten Public Offering - citybiz
Autonomix Medical Down 53% After Pricing of $9M Offering - MarketWatch
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views - Benzinga
Stock market news: Dragonfly Energy Holdings -88.31%, Autonomix Medical -53.33% among top stock losers during mid day trading - Business Upturn
Autonomix Medical slumps after $9 mln stock offering - XM
Stock market today: Dragonfly Energy Holdings -88.07%, Autonomix Medical -52.37% among top losers in early trading - Business Upturn
Dow Jumps 300 Points; Gap Posts Upbeat Earnings - Benzinga
Autonomix to sell 1.38M units at $6.54 in underwritten public offering - TipRanks
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering - GlobeNewswire
Autonomix Medical Prices $9M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket - Benzinga
A.M.AUTONOMY Showcases MAP-TORCH for 3D Construction Digitalization at KINTEX - GlobeNewswire Inc.
Autonomix Medical reports net loss of USD 2.8M in 3 months - Medical Buyer
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - The Manila Times
Autonomix reports Q2 incurred net losses $2.8M vs $6M last year - TipRanks
Autonomix Medical Inc (AMIX) Quarterly 10-Q Report - Quartz
Autonomix Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - BioSpace
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - MSN
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Autonomix announces preliminary results from trial on ablation technology - TipRanks
Autonomix Shares Soar 85% on Results From Pain-Management Study - MarketWatch
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday? - Benzinga
Autonomix (AMIX) Stock Soars On Positive Pain Management Trial Outcomes - Stocks Telegraph
Autonomix jumps after its treatment reduces pain during trial - XM
Autonomix reports breakthrough in pancreatic cancer pain - Investing.com India
Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - The Manila Times
Positive Preliminary Results Demonstrate Autonomix’s - GlobeNewswire
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - StockTitan
1,518,000 Common Stock of Autonomix Medical, Inc. are subject to a Lock-Up Agreement Ending on 27-OCT-2024. - Marketscreener.com
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th - GlobeNewswire
Autonomix Medical to conduct a reverse stock split - MSN
Autonomix Medical announces 1-for-20 reverse stock split By Investing.com - Investing.com Nigeria
Nerve ablation tech developer Autonomix to effect a reverse stock split - Mass Device
Autonomix Announces Reverse Stock Split - citybiz
Autonomix Medical Inc Azioni (AMIX) Dati Finanziari
Non sono disponibili dati finanziari per Autonomix Medical Inc (AMIX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):